84 related articles for article (PubMed ID: 11429580)
21. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
22. [Cyclin D1 and breast cancer: the good news of summer 2001].
Larsen CJ
Bull Cancer; 2001 Aug; 88(8):717-8. PubMed ID: 11578938
[No Abstract] [Full Text] [Related]
23. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
[TBL] [Abstract][Full Text] [Related]
25. Edging toward new therapeutics with cyclin D1 Egl'ng on cancer.
Dang CV
Cancer Cell; 2009 Nov; 16(5):361-2. PubMed ID: 19878865
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
27. Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.
Casimiro MC; Di Sante G; Crosariol M; Loro E; Dampier W; Ertel A; Yu Z; Saria EA; Papanikolaou A; Li Z; Wang C; Addya S; Lisanti MP; Fortina P; Cardiff RD; Tozeren A; Knudsen ES; Arnold A; Pestell RG
Oncotarget; 2015 Apr; 6(11):8525-38. PubMed ID: 25940700
[TBL] [Abstract][Full Text] [Related]
28. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
[TBL] [Abstract][Full Text] [Related]
29. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
30. Activation of cyclin D1 expression by the ERK5 cascade.
Mulloy R; Salinas S; Philips A; Hipskind RA
Oncogene; 2003 Aug; 22(35):5387-98. PubMed ID: 12934098
[TBL] [Abstract][Full Text] [Related]
31. Heterogenic loss of BRCA in breast cancer: the "two-hit" hypothesis takes a hit.
Meric-Bernstam F
Ann Surg Oncol; 2007 Sep; 14(9):2428-9. PubMed ID: 17406948
[No Abstract] [Full Text] [Related]
32. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
33. Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance.
Ahnström M; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Breast Cancer Res Treat; 2005 May; 91(2):145-51. PubMed ID: 15868442
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
[TBL] [Abstract][Full Text] [Related]
35. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
36. A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.
Maeda T; O-Wang J; Matsubara H; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2001 Nov; 8(11):890-6. PubMed ID: 11773979
[TBL] [Abstract][Full Text] [Related]
37. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
38. A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.
Altiok N; Mezzadra H; Patel P; Koyuturk M; Altiok S
Breast Cancer Res Treat; 2008 May; 109(2):315-23. PubMed ID: 17638069
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
40. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
